tlooto
Sign up
MedicineChemistry

Evolution of HCV NS5B Non-nucleoside Inhibitors

W. Watkins

2019Topics in Medicinal Chemistry

DOI: 10.1007/7355_2018_35

tlooto Summary

The HCV polymerase NS5B is susceptible to allosteric inhibition at four sites that have been exploited by compounds that have shown clinical efficacy.

Abstract

Abstract is not available.

Citation format

WATKINS, W. Evolution of HCV NS5B non-nucleoside inhibitors. Topics in Medicinal Chemistry, 2019.